Detailed answers about THE FEMININE HEALTH AND FIBROID SUPPORT NETWORK, including incorporation, status, business activity, and accounts information.
When was THE FEMININE HEALTH AND FIBROID SUPPORT NETWORK founded?
THE FEMININE HEALTH AND FIBROID SUPPORT NETWORK was officially incorporated on 22 July 2021 and is registered under company number 13524456. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is THE FEMININE HEALTH AND FIBROID SUPPORT NETWORK?
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of THE FEMININE HEALTH AND FIBROID SUPPORT NETWORK?
THE FEMININE HEALTH AND FIBROID SUPPORT NETWORK's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does THE FEMININE HEALTH AND FIBROID SUPPORT NETWORK do?
THE FEMININE HEALTH AND FIBROID SUPPORT NETWORK operates in the following sector: 96090 - Other service activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is THE FEMININE HEALTH AND FIBROID SUPPORT NETWORK's registered address?
The registered office address of THE FEMININE HEALTH AND FIBROID SUPPORT NETWORK is 71-75 SHELTON STREET, COVENT GARDEN, LONDON, UNITED KINGDOM, WC2H 9JQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is THE FEMININE HEALTH AND FIBROID SUPPORT NETWORK financially stable?
The most recent accounts for THE FEMININE HEALTH AND FIBROID SUPPORT NETWORK were made up to 31 July 2024, filed as MICRO ENTITY. Next accounts are due by 30 April 2026.